183 related articles for article (PubMed ID: 20150250)
1. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.
Buck AK; Herrmann K; Stargardt T; Dechow T; Krause BJ; Schreyögg J
J Nucl Med; 2010 Mar; 51(3):401-12. PubMed ID: 20150250
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.
Buck AK; Herrmann K; Stargardt T; Dechow T; Krause BJ; Schreyögg J
J Nucl Med Technol; 2010 Mar; 38(1):6-17. PubMed ID: 20197541
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?
Langer A
BMC Health Serv Res; 2010 Oct; 10():283. PubMed ID: 20932288
[TBL] [Abstract][Full Text] [Related]
4. [Cost-effective PET investigations in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Galuska L; Trón L; Esik O
Magy Onkol; 2002; 46(3):203-23. PubMed ID: 12368917
[TBL] [Abstract][Full Text] [Related]
5. Clinical applications of positron emission tomography-computed tomography in oncology.
Kumar R; Halanaik D; Malhotra A
Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
[TBL] [Abstract][Full Text] [Related]
6. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
van Loon J; Grutters JP; Wanders R; Boersma L; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Brans B; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
[TBL] [Abstract][Full Text] [Related]
7. PET/CT in non-small cell lung cancer staging-promises and problems.
Devaraj A; Cook GJ; Hansell DM
Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic imaging--PET, PET/CT--in oncologic surgery].
Garai I; Tóth C; Szabados L; Sóvágó J; Tóth L; Csiki Z
Magy Seb; 2008 Aug; 61(4):217-24. PubMed ID: 18799405
[TBL] [Abstract][Full Text] [Related]
9. [Cost-effective PET scans in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Várady E; Galuska L; Trón L; Esik O
Orv Hetil; 2002 May; 143(21 Suppl 3):1255-61. PubMed ID: 12077909
[TBL] [Abstract][Full Text] [Related]
10. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
11. PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.
Czernin J; Benz MR; Allen-Auerbach MS
Eur J Radiol; 2010 Mar; 73(3):470-80. PubMed ID: 20097498
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic use of positron emission tomography in France: from the coincidence gamma-camera to mobile hybrid PET/CT devices].
Talbot JN
Bull Acad Natl Med; 2010 Nov; 194(8):1559-76; discussion 1576-9. PubMed ID: 22046717
[TBL] [Abstract][Full Text] [Related]
13. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of PET-CT : product safety, clinical usefulness, reimbursement in Germany and the USA].
Biersack HJ
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jun; 52(6):594-600. PubMed ID: 19399376
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia PET/CT imaging: implications for radiation oncology.
Arabi M; Piert M
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):500-9. PubMed ID: 20927017
[TBL] [Abstract][Full Text] [Related]
16. PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response.
Heron DE; Andrade RS; Beriwal S; Smith RP
Am J Clin Oncol; 2008 Aug; 31(4):352-62. PubMed ID: 18845994
[TBL] [Abstract][Full Text] [Related]
17. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.
Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004
[TBL] [Abstract][Full Text] [Related]
18. FDG PET and PET/CT.
Krause BJ; Schwarzenböck S; Souvatzoglou M
Recent Results Cancer Res; 2013; 187():351-69. PubMed ID: 23179888
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma.
Krug B; Crott R; Roch I; Lonneux M; Beguin C; Baurain JF; Pirson AS; Vander Borght T
Acta Oncol; 2010; 49(2):192-200. PubMed ID: 20059314
[TBL] [Abstract][Full Text] [Related]
20. PET imaging: implications for the future of therapy monitoring with PET/CT in oncology.
Tomasi G; Rosso L
Curr Opin Pharmacol; 2012 Oct; 12(5):569-75. PubMed ID: 22901680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]